MFS
RNAC icon

Miller Financial Services’s Cartesian Therapeutics RNAC Stock Holding History

Miller Financial Services’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Hold
22,143
– – 0.19% 120
2026
Q1 		$136K Buy
22,143
+8,500
+62% +$60.6K 0.15% 110
2025
Q4 		$98.4K Buy
13,643
+2,000
+17% +$16.2K 0.12% 109
2025
Q3 		$119K Hold
11,643
– – 0.14% 109
2025
Q2 		$121K Buy
+11,643
New +$124K 0.15% 104

Other funds holding RNAC

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Miller Financial Services's RNAC Position: Q2 2026 in Review

Miller Financial Services held its Cartesian Therapeutics (RNAC) position steady in Q2 2026 at 22,143 shares worth $231K. The position accounts for 0.19% of the portfolio, ranked #120.

Miller Financial Services first reported a position in RNAC in Q2 2025 and has held it in 5 quarters since. 95 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Miller Financial Services held 22,143 shares of Cartesian Therapeutics worth $231K as of Q2 2026.
  • Miller Financial Services left its Cartesian Therapeutics share count unchanged in Q2 2026.
  • Cartesian Therapeutics made up 0.19% of Miller Financial Services's portfolio in Q2 2026, its #120 holding.
  • Miller Financial Services first reported a position in Cartesian Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Miller Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.